Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.86

+1.3%

Dec 24 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2692)	4/28/2010 12:00:16 PM
From: Jibacoa	Read Replies (1) of 3722

AFFX is bouncing up without completely closing its Febr4 UG.<g> The stock was up 9.93% and is stil up 7.92% at present on volume of > 1.3M stillbelow its ADV bigcharts.marketwatch.com On Monday it announced the launch of its Axiom Genome-Wide ASI Array, which supposedly is the first commercial product to provide maximum power for genome-wide association studies in East Asian populations. This is the second release for the Axiom Genotyping Solution, which includes a suite of population-optimized arrays for genomic studies that will be delivered in the next year. Last week AFFX reported the results for the 1stQ. The loss was approximately $9.6M, ( $0.14/shr), including an impairment charge of $4.9M on a non-marketable investment, vs.a loss of $25.2M ($0.37/shr) in 2009. The gross margin was 61.3% vs. 47% Revenue for the Q was $80.2M vs. $78.6M The EE for 2010 are around $0.04 vs. the loss of $0.56 in 2009 & for 2011 EE are around $0.15 <g> The ACTAY is $8.33. It seems that with some good news the stock could get to the $10 or $12 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next